25. Gupta A, Li R, Shair K, Gao SJ. Model Systems of Gammaherpesvirus Infection, Immunity, and Disease. J Med Virol. 2025 Sep;97(9):e70581. doi: 10.1002/jmv.70581. PMID: 40923861; PMCID: PMC12419141.
24. Sugiokto FG, Li R. Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges. Viruses. 2025 Jan 15;17(1). doi: 10.3390/v17010110. Review. PubMed PMID: 39861899.
23. Sugiokto FG, Li R*. Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir. mBio. 2024 Jun 14:e0079524. doi: 10.1128/mbio.00795-24. Epub ahead of print. PMID: 38874417.s
22. Floros KV, Fairchild CK, Li J, Zhang K, Roberts JL, Kurupi R, Hu B, Kraskauskiene V, Hosseini N, Shen S, Inge MM, Smith-Fry K, Li L, Sotiriou A, Dalton KM, Jose A, Abdelfadiel EI, Xing Y, Hill RD, Slaughter JM, Shende M, Lorenz MR, Hinojosa MR, Belvin BR, Lai Z, Boikos SA, Stamatouli AM, Lewis JP, Manjili MH, Valerie K, Li R, Banito A, Poklepovic A, Koblinski JE, Siggers T, Dozmorov MG, Jones KB, Radhakrishnan SK, Faber AC. Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma. bioRxiv. 2024 Apr 27;. doi: 10.1101/2024.04.25.591023. PubMed PMID: 38712286; PubMed Central PMCID: PMC11071469.
21. Sugiokto FG, Saiada F, Zhang K, and Li R*. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication. mBio. (2024).
20. James CD, Youssef A, Prabhakar AT, Otoa R, Witt A, Lewis RL, Bristol ML, Wang X, Zhang K, Li R, Morgan IM. Human Papillomavirus 16 replication converts SAMHD1 into a homologous recombination factor and promotes its recruitment to replicating viral DNA. bioRxiv. 2023 Nov 15;. doi: 10.1101/2023.11.13.566899. (Accepted by Journal of Virology)
19. Prabhakar AT, James CD, Das D, Otoa R, Day M, Burgner JW, Fontan CT, Wang X, Wieland A, Donaldson MM, Bristol ML, Li R, Oliver A, Pearl LH, Smith BO and Morgan IM. CK2 phosphorylation of human papillomavirus 16 E2 on serine 23 promotes interaction with TopBP1 and is critical for E2 plasmid retention function. mBio. (2021).
18. Zhang K, Zhang Y, Maharjan Y, Sugiokto FG, Wan J and Li R*. Caspases switch off m6A RNA modification pathway to foster the replication of a ubiquitous human tumor virus. BioRxiv. (Nov 2020). mBio (Aug 2021)
17. Saiada F, Zhang K, and Li R*. PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation. Cell & Bioscience. (2021)
16. Zheng Y, Li R* and Liu S* (2020) Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines. Journal of Medical Virology. (Selected as Journal Cover Story).
15. Zhang K#, Lv DW# and Li R* (2020) Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression. Virology. 2020; 540: 75-87.
14. James CD, Prabhakar AT, Evans MR, Wang X, Bristol ML, Zhang K, Li R and Morgan IM (2019). SAMHD1 regulates human papillomavirus 16 induced cell proliferation and viral replication during differentiation of keratinocytes. mSphere. 2019 Aug 7;4(4). doi: 10.1128/mSphere.00448-19. PubMed PMID: 31391281.
13. Zhang K, Lv DW and Li R* (2019) Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus Replication. Cell Reports. 2019; 28: 449-459.
12. Lv DW#, Zhang K#and Li R* (2018) Interferon Regulatory Factor 8 Regulates Caspase-1 Expression to Facilitate Epstein-Barr Virus Reactivation in Response to B Cell Receptor Stimulation and Chemical Induction. PLOS Pathogens. 2018 Jan 22;14(1):e1006868. doi: 10.1371/journal.ppat.1006868.
11. Zhang K, Lv DW and Li R*. (2017). B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation. Cell Reports. 21: 3445-3457. F1000 Recommended.
10. Lv DW, Zhong J, Zhang K, Pandey A and Li R* (2017). Understanding Epstein-Barr Virus Life Cycle with Proteomics: A Temporal Analysis of Ubiquitination during Virus Reactivation. OMICS: A Journal of Integrative Biology. 21(1), 27-37.
9. Li R*, Liao G, Nirujogi RS, Pinto SM, Shaw PG, Huang TC, Wan J, Qian J, Gowda H, Wu X, Lv DW, Zhang K, Manda SS, Pandey A* and Hayward SD* (2015). Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling. PLoS pathogens 11, e1005346.
8. Li R and Hayward SD (2013). Potential of protein kinase inhibitors for treating herpesvirus associated disease. Trends in Microbiology 21(6), 286-295.
7. Woodard C, Shamay M, Liao G, Zhu J, Ng AN, Li R, Newman R, Rho HS, Hu J, Wan J, Qian J, Zhu H & Hayward SD (2012). Phosphorylation of the Chromatin Binding Domain of KSHV LANA. PLOS Pathogens. 8(10):e1002972.
6. Li R#, Wang L#, Liao G, Guzzo CM, Matunis MJ, Zhu H and Hayward SD (2012). SUMO Binding by the Epstein-Barr Virus Protein Kinase BGLF4 is Crucial for BGLF4 Function. J Virol 86(10), 5412-21.
5. Shamay M, Liu J, Li R, Liao G, Shen L, Greenway M, Hu S, Zhu J, Xie Z, Ambinder RF, Qian J, Zhu H and Hayward SD (2012). A Protein Array Screen for Kaposi's Sarcoma-Associated Herpesvirus LANA Interactors Links LANA to TIP60, PP2A Activity, and Telomere Shortening. J Virol 86(9), 5179-91.
4. Li R#, Zhu J#, Xie Z, Liao G, Liu J, Chen MR, Hu S, Woodard C, Lin J, Taverna SD, Desai P, Ambinder RF, Hayward GS, Qian J, Zhu H and Hayward SD (2011). Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10(4), 390-400.
3. Li R and Hayward SD (2011). The Ying-Yang of the virus-host interaction: control of the DNA damage response. Future Microbiol 6(4), 379-83.
2. Li RF, Shang Y, Liu D, Ren ZS, Chang Z and Sui SF (2007). Differential ubiquitination of Smad1 mediated by CHIP: implications in the regulation of the bone morphogenetic protein signaling pathway. J Mol Biol 374(3), 777-90.
1. Li RF, Zhang F, Lu YJ and Sui SF (2005). Specific interaction between Smad1 and CHIP: a surface plasmon resonance study. Colloids Surf B Biointerfaces 40(3-4), 133-6.